The recalled lot carries an expiration date of September 30, 2027. No injuries have been reported so far.

A UCLA professor says the laser adds cash on top of Medicare pay, even as one patient shelled out nearly $4,000 for two eyes.

American Regent pulled two lots each of Adequan Canine and Adequan i.m. after glass fibers turned up in vials shipped since 2024.

Provisional federal counts put overdose deaths above 73,000 in the 12 months ending April 2025 as officials renew warnings about fentanyl‑laced counterfeit pills.

A SPECT‑CT scan using 99mTc‑maraciclatide lit up early endometriosis in a small trial; a larger phase 3 with U.K. and U.S. cohorts is planned.

Bionpharma has recalled 500 mg Depakote bottles after foreign pills were found in some packages. Check NDC 69452‑435‑30 and talk with your pharmacist before changing treatment.

Fourteen U.S. citizens were briefly quarantined at Fort Drum after returning from the DRC amid a Bundibugyo Ebola outbreak; none showed symptoms and all were released.

Africa CDC director Jean Kaseya has asked the U.S. to rescind Ebola travel limits on Uganda after Kampala discharged its last confirmed patient and began WHO’s 42‑day countdown.

A JAMA case series and federal actions have spotlighted rare vision injuries tied to semaglutide and tirzepatide while regulators clamp down on a growing gray market. Patients are urged to verify prescriptions and report problems.

A D.C. committee put permit applications for the city's harm‑reduction vending machines on hold after neighborhood complaints about needles and loitering. The pause forces DC Health to clarify ownership and upkeep while researchers and residents spar over safety and access.

HHS has asked the FDA to revise testosterone prescribing information, removing an age‑related limit and updating prostate and blood‑pressure warnings.

A New England Journal of Medicine paper proposing organ removal linked to euthanasia has reignited a fierce ethics debate over consent and public trust.

A JAMA Network Open analysis shows many U.S. eighth‑graders underestimate the danger of fentanyl; local data show adolescent fentanyl deaths have surged.